Changes in G2066 Pricing Effective April 1, 2023

After reviewing Medicare claims data for G2066 (Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results], as well as seeking inputs from providers, industry, consultants, and other parties, National Government Services has reevaluated our payments for G2066.  The new NGS G2066 rates will be effective April 1, 2023 and will be posted on our website.

Posted 3/27/2023